Conference on Bioinformation and Translational Medicine held in Beijing
The first Conference on Bioinformation and Translational Medicine took place in Huairou district, Beijing, from Oct 13 to 14.
Initiated by the Academic Subgroup of Biomedical Information of the Biophysical Society of China (BSC), the academic event was jointly hosted by the subgroup and the management committee of Huairou Science City.
Bo Xiaochen, research fellow at the Academy of Military Medical Sciences of the PLA Academy of Military Sciences and chair of the conference, delivers an opening address. [Photo/WeChat account: BSC]
In his opening address, Bo Xiaochen, research fellow at the Academy of Military Medical Sciences of the PLA Academy of Military Sciences and chair of the conference, underscored the need for a new paradigm in international biomedical development, in response to evolving circumstances.
Bo called on researchers to share their experiences, urging bioinformatics to transcend the confines of basic research and integrate with translational medicine, thereby better serving public health.
He also provided insight into the origins and evolution of the BSC Academic Subgroup of Biomedical Information, emphasizing its pivotal role in fostering improved communication and growth in China’s biomedical informatics.
Qin Hongxia, an official from the management committee of Huairou Science City, highlighted the critical role of bioinformation in preventing and controlling emerging infectious diseases and affirmed its function in promoting the application of translational medicine.
The first Conference on Bioinformation and Translational Medicine takes place in Huairou district, Beijing, from Oct 13 to 14. [Photo/WeChat account: BSC]
The conference featured keynote lectures with a focus on the applications of bioinformation-driven translational medicine. Topics covered a wide spectrum, including the application of multi-omics analysis techniques in translational medicine, onco-omics analysis and the discovery of biomarkers, the development of microbiomics and its application in the diagnosis and treatment of infectious diseases, and artificial intelligence-based medical big data mining.
Special reports delved into the cutting-edge advancements in genomic variations in tumors, the discovery and validation of biomarkers, the detection and prevention of infectious pathogens, and the structure and functions of microbiome. The conference also explored the utilization of AI techniques in the analysis and mining of medical big data, in order to improve disease diagnosis and treatment.